Estela Martín‐Clavero

Novel treatment strategy with autologous activated and expanded natural killer cells plus anti-myeloma drugs for multiple myeloma

Alejandra Leivas, Antonio Pérez‐Martínez, María Jesús Blanchard et al. · OncoImmunology · 2016 · 84 citations · Full text

Interobserver variance in myelodysplastic syndromes with less than 5 % bone marrow blasts: unilineage vs. multilineage dysplasia and reproducibility of the threshold of 2 % blasts

Patricia Font, Javier Loscertales, Carlos Soto et al. · Annals of Hematology · 2014 · 81 citations

Hematological Malignancy, Multilineage Dysplasia, Bone Marrow Failure +7

The clinical significance of stringent complete response in multiple myeloma is surpassed by minimal residual disease measurements

María‐Teresa Cedena, Estela Martín‐Clavero, Sandy W. Wong et al. · PLoS ONE · 2020 · 24 citations · Full text

Dramatic resolution of disseminated pyoderma gangrenosum associated with monoclonal gammopathy after therapy with bortezomib and dexamethasone

Virginia Velasco‐Tamariz, Gonzalo Carreño‐Tarragona, Fátima Tous‐Romero et al. · International Wound Journal · 2017 · 13 citations · Full text